DaVita plays down Ozempic’s potential in treating kidney disease By: MarketWatch October 12, 2023 at 12:42 PM EDT Dialysis company DaVita is not convinced a Novo Nordisk trial's findings relating to its Ozempic treatment will be borne out over time. Read More >> Related Stocks: DaVita HealthCare Partner
